Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
THERAVANCE BIOPHARMA R&D IP LLC	901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080

International Classification(s)

• C07D:HETEROCYCLIC COMPOUNDS

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Fleury, Melissa	San Francisco, US	110	1148
Gendron, Roland	San Francisco, US	84	1167
Hughes, Adam D	Belmont, US	109	1192

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Mar 1, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
September 01, 2015	US,9120747,B2   US9120747B2	GRANTED PATENT AS SECOND PUBLICATION
February 13, 2014	US,20140046053,A1   US20140046053A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9120747

Neprilysin inhibitors

---

 

Legal Events